Systematic Review and Meta-analysis of Outcomes of Patients With Subsegmental Pulmonary Embolism With and Without Anticoagulation Treatment
Systematic review and meta-analysis published in Academic emergency medicine : official journal of the Society for Academic Emergency Medicine (2018)
Resumen
BACKGROUND: This systematic review addresses the controversy over the decision to anticoagulate patients with subsegmental pulmonary embolism (SSPE). METHODS: We searched Ovid MEDLINE, PubMed, Embase, the Cochrane Library, Scopus, Web of Science, ClinicalTrials.gov, Google Scholar, and bibliographies in March 2017. Two authors reviewed and retained papers with symptomatic patients who underwent computerized tomographic pulmonary angiography and had sufficient information to determine SSPE; decision to treat (or not) with systemic anticoagulation; and outcomes of bleeding, venous thromboembolism (VTE) recurrence, and death. Papers were assessed for selection and publication bias and heterogeneity, with Eggers and the inconsistency indexes (I2 ). RESULTS: From 1,512 papers screened, we included 14 studies comprising 15,563 patients for full-length review and analysis. Pooled data demonstrated I2 = 99% with an Eggers p < 0.001, suggesting significant publication bias. The pooled prevalence of SSPE was 4.6% (95% confidence interval [CI] = 1.8%-8.5%). The frequency of bleeding in SSPE patients treated with anticoagulation (n = 589) was 8.1% (95% CI = 2.8%-15.8%), with no available bleeding data in untreated patients (n = 126). The frequency of VTE recurrence within 90 days was 5.3% (95% CI = 1.6%-10.9%) for treated versus 3.9% (95% CI = 4.8%-13.4%) for untreated, while the frequency of death was 2.1% (95% CI = 3.4%-5.2%) for treated versus 3.0% (95% CI = 2.8%-8.6%) for untreated. CONCLUSION: This systematic review highlights the lack of any clinical trial to make a clear inference about harm or benefit of anticoagulation for SSPE. Comparison of pooled data from uncontrolled outcome studies shows no increase in VTE recurrence or death rates for patients who were not anticoagulated. These data suggest clinical equipoise for decision to anticoagulate or not anticoagulate patients with SSPE. However, this inference is limited by small numbers, imprecision, and the lack of a controlled clinical trial.
Resumen tomado de PubMed (NCBI) para el registro citado, en el idioma original. La versión de referencia es la de la publicación original.
El resumen se deja sin traducir para conservar la redacción original de los autores.
Síntesis
Systematic review of 14 studies comprising 15,563 patients with subsegmental pulmonary embolism found pooled VTE recurrence of 5.3% with anticoagulation versus 3.9% without, and no difference in death rates, suggesting clinical equipoise for treatment decisions.
Por qué esto importa para la hirudoterapia
Esta revisión sistemática y metaanálisis agrupó 14 estudios (15,563 pacientes) para analizar si la embolia pulmonar subsegmentaria (SSPE) debe ser anticoagulada, y no encontró un aumento claro en la recurrencia de VTE o muerte entre los pacientes que no recibieron tratamiento, concluyendo que existe un equilibrio clínico y que no hay ningún ensayo controlado que determine el daño frente al beneficio. Para ASH, el valor es contextual más que directo: ilustra cuán escasa y cuestionada puede ser la base de evidencia de la anticoagulación incluso para una indicación convencional, que es la misma arena de balance entre trombosis y sangrado a la que finalmente se refiere la historia del anticoagulante salival de la sanguijuela (hirudin y moléculas relacionadas del secretoma). Advertencia honesta: este artículo trata sobre fármacos anticoagulantes sistémicos para SSPE, no sobre hirudoterapia ni ningún agente derivado de sanguijuelas, y los propios autores subrayan que los datos están limitados por números pequeños, una heterogeneidad severa, sesgo de publicación y la ausencia de cualquier RCT.
Citación
Systematic Review and Meta-analysis of Outcomes of Patients With Subsegmental Pulmonary Embolism With and Without Anticoagulation Treatment.
Bariteau et al. · Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2018
Contexto clínico relacionado
Explore cómo esta investigación se conecta con la práctica clínica
Investigación relacionada
Más estudios revisados por pares en la categoría «Ensayos clínicos».
- Leech Therapy for Knee Osteoarthritis — The Landmark RCT — Michalsen et al. (2003)
- Leech-Assisted Flap Salvage — Systematic Review of 277 Cases — Whitaker et al. (2012)
- Effects of hirudotherapy on liver functions, lipid profile, and insulin sensitivity in rats with metabolic syndrome — Bilden A et al. (2026)
- Efficacy and Safety of Hirudotherapy for Improving Sperm Quality Parameters in Male Infertility: A Randomized Controlled Trial — Abtahi-Forooshani M et al. (2026)
- Reverse Sural Flap Venous Congestion Successfully Managed With Enoxaparin in a Male Patient With a Traumatic Foot Crush Injury: A Case Report — Velasco-Bustamante J et al. (2026)
- Investigación de los efectos terapéuticos del tratamiento con sanguijuelas medicinales sobre la lesión por isquemia-reperfusión de la extremidad inferior — Ünal K et al. (2026)
- Efficacy of Medicinal Leech Therapy in Diverse Clinical Applications: A Comprehensive Study from Azerbaijan — Farzali S et al. (2025)
- HIRUDOTHERAPY IN RECONSTRUCTIVE SURGERY: CASE-REPORTS AND REVIEW — Heinz P et al. (2020)
- Hirudoterapia en la cicatrización de heridas — Nair H et al. (2022)
- Improvement of patient care through hirudotherapy and the management of leeches from their reception to their disposal in France — Vaesken C et al. (2023)
Añadido a la biblioteca ASH: 28 de mayo de 2026 · Última actualización del sitio: 18 de junio de 2026